180 related articles for article (PubMed ID: 19319465)
1. Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.
Yoshiji H; Noguchi R; Kitade M; Kaji K; Ikenaka Y; Namisaki T; Yoshii J; Yanase K; Yamazaki M; Tsujimoto T; Akahane T; Kawaratani H; Uemura M; Fukui H
J Gastroenterol; 2009; 44(5):483-91. PubMed ID: 19319465
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats.
Yoshiji H; Noguchi R; Kaji K; Ikenaka Y; Shirai Y; Namisaki T; Kitade M; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol; 2010 Apr; 45(4):443-50. PubMed ID: 19941011
[TBL] [Abstract][Full Text] [Related]
3. Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance.
Yoshiji H; Noguchi R; Namisaki T; Moriya K; Kitade M; Aihara Y; Douhara A; Yamao J; Fujimoto M; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Uejima M; Uemura M; Fukui H
Oncol Rep; 2013 Aug; 30(2):545-52. PubMed ID: 23708326
[TBL] [Abstract][Full Text] [Related]
4. Impact of insulin resistance on the progression of chronic liver diseases.
Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Yoshii J; Yanase K; Namisaki T; Yamazaki M; Moriya K; Tsujimoto T; Kawaratani H; Akahane T; Uemura M; Fukui H
Int J Mol Med; 2008 Dec; 22(6):801-8. PubMed ID: 19020779
[TBL] [Abstract][Full Text] [Related]
5. Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats.
Nishimura N; Kaji K; Kitade M; Aihara Y; Sato S; Seki K; Sawada Y; Takaya H; Okura Y; Kawaratani H; Moriya K; Namisaki T; Mitoro A; Yoshiji H
BMC Cancer; 2018 Nov; 18(1):1164. PubMed ID: 30477453
[TBL] [Abstract][Full Text] [Related]
6. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
[TBL] [Abstract][Full Text] [Related]
7. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Masaki T; Fukui H
J Hepatol; 2005 May; 42(5):687-93. PubMed ID: 15826718
[TBL] [Abstract][Full Text] [Related]
8. Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.
Nishimura N; Kitade M; Noguchi R; Namisaki T; Moriya K; Takeda K; Okura Y; Aihara Y; Douhara A; Kawaratani H; Asada K; Yoshiji H
J Gastroenterol; 2016 Dec; 51(12):1141-1149. PubMed ID: 27025708
[TBL] [Abstract][Full Text] [Related]
9. Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.
Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Yamazaki M; Yamao J; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Fujimoto M; Uemura M; Fukui H
Oncol Rep; 2011 Dec; 26(6):1547-53. PubMed ID: 21874260
[TBL] [Abstract][Full Text] [Related]
10. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.
Iwasa J; Shimizu M; Shiraki M; Shirakami Y; Sakai H; Terakura Y; Takai K; Tsurumi H; Tanaka T; Moriwaki H
Cancer Sci; 2010 Feb; 101(2):460-7. PubMed ID: 19906067
[TBL] [Abstract][Full Text] [Related]
11. Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Anticancer Res; 2005; 25(5):3335-40. PubMed ID: 16101147
[TBL] [Abstract][Full Text] [Related]
12. Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.
Kitade M; Yoshiji H; Kojima H; Ikenaka Y; Noguchi R; Kaji K; Yoshii J; Yanase K; Namisaki T; Asada K; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
Hepatology; 2006 Oct; 44(4):983-91. PubMed ID: 17006938
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.
Yoshiji H; Kuriyama S; Fukui H
Tumour Biol; 2002; 23(6):348-56. PubMed ID: 12677092
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
Miuma S; Ichikawa T; Arima K; Takeshita S; Muraoka T; Matsuzaki T; Ootani M; Shibata H; Akiyama M; Ozawa E; Miyaaki H; Taura N; Takeshima F; Nakao K
J Cell Biochem; 2012 Oct; 113(10):3113-21. PubMed ID: 22581719
[TBL] [Abstract][Full Text] [Related]
15. Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis.
Yoshiji H; Noguchi R; Namisaki T; Moriya K; Kitade M; Aihara Y; Douhara A; Kawaratani H; Nishimura N; Fukui H
J Gastroenterol; 2014 Oct; 49(10):1421-9. PubMed ID: 24197250
[TBL] [Abstract][Full Text] [Related]
16. Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling.
Zhao H; Zhang F; Sun D; Wang X; Zhang X; Zhang J; Yan F; Huang C; Xie H; Lin C; Liu Y; Fan M; Yan W; Chen Y; Lian K; Li Y; Zhang L; Wang S; Tao L
Diabetes; 2020 Jun; 69(6):1164-1177. PubMed ID: 32184272
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
18. Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.
Noguchi R; Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Mitoro A; Tsujinoue H; Imazu H; Masaki T; Fukui H
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6038-45. PubMed ID: 14676130
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.
Sakai H; Shirakami Y; Shimizu M
World J Gastroenterol; 2016 Jan; 22(1):394-406. PubMed ID: 26755885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
